Literature DB >> 17140157

Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3.

B O Evert1, J Schelhaas, H Fleischer, R A I de Vos, E R Brunt, W Stenzel, T Klockgether, U Wüllner.   

Abstract

OBJECTIVE: We analyzed the expression of the inflammatory mediators IL-1beta, IL-1ra, IL-6 and the transcription factors IRF-1 and C/EBPdelta (previously identified in a transgenic model of spinocerebellar ataxia type 3 (SCA3) by gene expression profiling) in the central nervous system of SCA3 patients in relation to neuronal cell loss and ataxin-3-positive neuronal intranuclear inclusions (NI), to identify a putative upregulation of cytokines or microglia in SCA3 brains and to investigate whether enhanced cytokine expression was a generalized event mediating neuronal dysfunction in SCA3.
MATERIALS AND METHODS: Light- and electronmicroscopic immunohistochemistry was performed on SCA3 tissues derived from five patients from unrelated families with genetically confirmed diagnosis, and six individuals without a history of neurological or inflammatory disease.
RESULTS: NI were found almost exclusively in brain regions that also showed neuronal cell loss, i.e. in pons and dentate nucleus neurons, rarely in putamen and thalamus, but not in cerebral or cerebellar cortex. NI displayed an irregular surface and were mostly attached to the nucleoli. Quantitative analysis of NI in the pons revealed an inverse relation of NI and cell loss, i.e. patients with more severe neuronal cell loss had a smaller proportion of neurons with NI. Thus, formation of NI is not necessarily an indicator of cell death but could exert a protective effect. We found increased expression of IL-1beta, IL-1ra, IL-6 and C/EBPdelta only in pons and dentate nucleus neurons and both in neurons with and without NI, suggesting that NI are not a prerequisite for transcriptional changes.
CONCLUSIONS: Our data suggest that the selectively affected neuronal populations in SCA3 undergo a complex alteration of gene expression independent from the formation of NI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17140157

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  15 in total

Review 1.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

2.  Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients.

Authors:  Mafalda Raposo; Conceição Bettencourt; Amanda Ramos; Nadiya Kazachkova; João Vasconcelos; Teresa Kay; Jácome Bruges-Armas; Manuela Lima
Journal:  Neuromolecular Med       Date:  2016-05-31       Impact factor: 3.843

3.  Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.

Authors:  Yang Yang; Su Yang; Jifeng Guo; Yiting Cui; Beisha Tang; Xiao-Jiang Li; Shihua Li
Journal:  J Neurosci       Date:  2017-08-18       Impact factor: 6.167

4.  Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways.

Authors:  Andreia Teixeira-Castro; Michael Ailion; Ana Jalles; Heather R Brignull; João L Vilaça; Nuno Dias; Pedro Rodrigues; João F Oliveira; Andreia Neves-Carvalho; Richard I Morimoto; Patrícia Maciel
Journal:  Hum Mol Genet       Date:  2011-05-05       Impact factor: 6.150

5.  White matter damage is related to ataxia severity in SCA3.

Authors:  J-S Kang; J C Klein; S Baudrexel; R Deichmann; D Nolte; R Hilker
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

Review 6.  Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.

Authors:  Kritika Raj; Ravi Shankar Akundi
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

Review 7.  The role of the immune system in triplet repeat expansion diseases.

Authors:  Marta Olejniczak; Martyna O Urbanek; Wlodzimierz J Krzyzosiak
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

8.  Calcium dysregulation via L-type voltage-dependent calcium channels and ryanodine receptors underlies memory deficits and synaptic dysfunction during chronic neuroinflammation.

Authors:  Sarah C Hopp; Heather M D'Angelo; Sarah E Royer; Roxanne M Kaercher; Alexis M Crockett; Linda Adzovic; Gary L Wenk
Journal:  J Neuroinflammation       Date:  2015-03-25       Impact factor: 8.322

Review 9.  Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view.

Authors:  Giulia Coarelli; Alexis Brice; Alexandra Durr
Journal:  F1000Res       Date:  2018-11-12

10.  Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease.

Authors:  Sofia Esteves; Sara Duarte-Silva; Luana Naia; Andreia Neves-Carvalho; Andreia Teixeira-Castro; Ana Cristina Rego; Anabela Silva-Fernandes; Patrícia Maciel
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.